pH-dependent modulation of connexin-based gap junctional uncouplers

Journal of Physiology

Volumn 589, Issue 14, 2011, Pages 3495-3506

  Skeberdis, Vytenis A ^a,b   Rimkute, Lina ^a,b   Skeberdyte, Aiste ^a   Paulauskas, Nerijus ^a,b   Bukauskas, Feliksas F ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; ARACHIDONIC ACID; CARBENOXOLONE; CONNEXIN 26; CONNEXIN 30; CONNEXIN 30.2; CONNEXIN 36; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; CONNEXIN 46; CONNEXIN 47; CONNEXIN 50; FLUFENAMIC ACID; GAP JUNCTION PROTEIN; HISTIDINE; ISOFLURANE; MEFLOQUINE; N BROMOSUCCINIMIDE; OCTANOL; UNCLASSIFIED DRUG;

ALKALINIZATION; ARTICLE; CONTROLLED STUDY; GAP JUNCTION; HELA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; IC 50; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BROMOSUCCINIMIDE; CELL COMMUNICATION; CELLS, CULTURED; CONNEXINS; GAP JUNCTIONS; HELA CELLS; HUMANS; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; OCTANOLS; PROTEIN ISOFORMS;

EID: 79960358642     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.209072     Document Type: Article

References (40)

1. Beahm DL & Hall JE (2002). Hemichannel and junctional properties of connexin 50. Biophys J 82, 2016-2031.
2. Bennett MV (1994). Connexins in disease [news]. Nature 368, 18-19.
3. Bukauskas FF, Bukauskiene A, Verselis VK & Bennett MVL (2002). Coupling asymmetry of heterotypic connexin 45/connexin 43-EGFP gap junctions: Properties of fast and slow gating mechanisms. Proc Natl Acad Sci U S A 99, 7113-7118.
4. Bukauskas FF & Verselis VK (2004). Gap junction channel gating. Biochim Biophys Acta 1662, 42-60.
5. Burt JM & Spray DC (1989). Volatile anesthetics block intercellular communication between neonatal rat myocardial cells. Circ Res 65, 829-837.
6. Bushara KO, Goldstein SR, Grimes GJ, Burstein AH & Hallett M (2004). Pilot trial of 1-octanol in essential tremor. Neurology 62, 122-124.
7. Cruikshank SJ, Hopperstad M, Younger M, Connors BW, Spray DC & Srinivas M (2004). Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci U S A 101, 12364-12369.
8. Davidson JS & Baumgarten IM (1988). Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharmacol Exp Ther 246, 1104-1107.
9. Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF & Willecke K (1995). Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129, 805-817.
10. González-Nieto D, Gómez-Hernández JM, Larrosa B, Gutiérrez C, Muñoz MD, Fasciani I, O'Brien J, Zappalà A, Cicirata F & Barrio LC (2008). Regulation of neuronal connexin-36 channels by pH. Proc Natl Acad Sci U S A 105, 17169-17174.
11. Goodenough DA, Goliger JA & Paul DL (1996). Connexins, connexons, and intercellular communication. Annu Rev Biochem 65, 475-502.
12. Harks EG, de Roos AD, Peters PH, de Haan LH, Brouwer A, Ypey DL, van Zoelen EJ & Theuvenet AP (2001). Fenamates: a novel class of reversible gap junction blockers. J Pharmacol Exp Ther 298, 1033-1041.
13. Harris AL (2001). Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 34, 325-427.
14. Harris AL, Spray DC & Bennett MVL (1981). Kinetic properties of a voltage-dependent junctional conductance. J Gen Physiol 77, 95-117.
15. Hille B (2001). Ionic Channels of Excitable Membranes. Sinauer Associates, Sunderland, MA, USA.
16. Kreuzberg MM, Willecke K & Bukauskas F (2006). Connexin-mediated cardiac impulse propagation: Connexin 30.2 slows atrioventricular conduction in mouse heart. Trends Cardiovasc Med 16, 266-272.
17. Lampe PD & Lau AF (2004). The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36, 1171-1186.
18. Martin FC & Handforth A (2006). Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor. Mov Disord 21, 1641-1649.
19. Meyer RA, Laird DW, Revel JP & Johnson RG (1992). Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol 119, 179-189.
20. Palacios-Prado N, Briggs SW, Skeberdis VA, Pranevicius M, Bennett MV & Bukauskas FF (2010). pH-dependent modulation of voltage gating in connexin45 homotypic and connexin45/connexin43 heterotypic gap junctions. Proc Natl Acad Sci U S A 107, 9897-9902.
21. Palacios-Prado N, Sonntag S, Skeberdis VA, Willecke K & Bukauskas FF (2009). Gating, permselectivity and pH-dependent modulation of channels formed by connexin57, a major connexin of horizontal cells in the mouse retina. J Physiol 587, 3251-3269.
22. Paul DL (1986). Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 103, 123-134.
23. Paulauskas N, Pranevicius M, Pranevicius H & Bukauskas FF (2009). A stochastic four-state model of contingent gating of gap junction channels containing two 'fast' gates sensitive to transjunctional voltage. Biophys J 96, 3936-3948.
24. Rackauskas M, Neverauskas V & Skeberdis VA (2010). Diversity and properties of connexin gap junction channels. Medicina 46, 1-12.
25. Rackauskas M, Verselis VK & Bukauskas FF (2007). Permeability of homotypic and heterotypic gap junction channels formed of cardiac connexins mCx30.2, Cx40, Cx43, and Cx45. Am J Physiol Heart Circ Physiol 293, H1729-H1736.
26. Rozental R, Srinivas M & Spray DC (2001). How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol Biol 154, 447-476.
27. a prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des 21, 681-691.
28. Spray DC & Burt JM (1990). Structure-activity relations of the cardiac gap junction channel. Am J Physiol Cell Physiol 258, C195-C205.
29. Spray DC, Rozental R & Srinivas M (2002). Prospects for rational development of pharmacological gap junction channel blockers. Curr Drug Targets 3, 455-464.
30. Srinivas M (2009). Pharmacology of connexin channels. In Connexins: a Guide, ed. Harris AL & Locke D, pp. 207-224. Humana Press, New York.
31. Srinivas M, Hopperstad MG & Spray DC (2001). Quinine blocks specific gap junction channel subtypes. Proc Natl Acad Sci U S A 98, 10942-10947.
32. Srinivas M & Spray DC (2003). Closure of gap junction channels by arylaminobenzoates. Mol Pharmacol 63, 1389-1397.
33. Sun Z, Zhang DQ & McMahon DG (2009). Zinc modulation of hemi-gap-junction channel currents in retinal horizontal cells. J Neurophysiol 101, 1774-1780.
34. Swietach P & Vaughan-Jones RD (2005). Relationship between intracellular pH and proton mobility in rat and guinea-pig ventricular myocytes. J Physiol 566, 793-806.
35. Tamalu F, Chiba C & Saito T (2001). Gap junctional coupling between progenitor cells at the retinal margin of adult goldfish. J Neurobiol 48, 204-214.
36. Thomas JA, Buchsbaum RN, Zimniak A & Racker E (1979). Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18, 2210-2218.
37. Trexler EB, Bukauskas FF, Bennett MVL, Bargiello TA & Verselis VK (1999). Rapid and direct effects of pH on connexins revealed by the connexin46 hemichannel preparation. J Gen Physiol 113, 721-742.
38. Valiunas V (2002). Biophysical properties of connexin-45 gap junction hemichannels studied in vertebrate cells. J Gen Physiol 119, 147-164.
39. Verselis VK, Trelles MP, Rubinos C, Bargiello TA & Srinivas M (2009). Loop gating of connexin hemichannels involves movement of pore-lining residues in the first extracellular loop domain. J Biol Chem 284, 4484-4493.
40. Wilders R & Jongsma HJ (1992). Limitations of the dual voltage clamp method in assaying conductance and kinetics of gap junction channels. Biophys J 63, 942-953.